Pay in 4 interest-free payments of $5.37 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Research Focus (non-clinical) Investigation of amino acid and vitamin cofactor roles in metabolic pathways Studies on lipid metabolism and methylation cycle regulation Development of analytical assays for multi-component solution characterization Stability, sterility, and pH profiling under laboratory storage conditions For qualified research professionals and institutional laboratories
Sales: $26.1 Billion Headcount: 9,000 Revenues: $26,107 (-13%) Net Income: $4,628 (-66%) R&D: $3,734 (-27%) TOP SELLING DRUGS Antiviral product sales for Gilead, which make up the bulk of its revenue and include HIV, chronic hepatitis B (HBV) and chronic hepatitis C (HCV) products, were $23.3 billion compared to $27.7 billion in 2016
Essential Nutrients Galore: Yerba Mate isn't just about antioxidants
Although there is no close relationship between plasma VPA concentrations and the severity of CNS toxicity [11, 86], patients who ingest more than 200 mg/kg VPA and/or have plasma concentrations greater than 180 g/ml usually develop severe CNS depression
S suy gim GLP-1 ngi mc i tho ng tup 2 l mt yu t quan trng nh hng n vic qun l bnh
Pipeline and Emerging Drug Innovations Pipeline developments of GLP-1 analogues are aimed at better treatment options for individuals suffering from diabetes and obesity
US$ 24.91
US$ 25.85
US$ 28.04
